In Brief: OraVax/bioMerieux Vitek:
This article was originally published in The Gray Sheet
Executive Summary
OraVax/bioMerieux Vitek: Enter licensing agreement under which St. Louis, Missouri-based bioMerieux gains exclusive, worldwide rights to develop diagnostic tests incorporating Cambridge, Massachusetts-based OraVax's proprietary CagA Helicobacter pylori antigen. OraVax is investigating use of the CagA antigen for use in H. pylori vaccines...